Probiotics: An Emerging Therapy
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
There is considerable clinical interest in the utility of probiotic therapy--the feeding of (live) non-pathogenic bacteria, originally derived from the alimentary tract, for disease treatment or health promotion. The microflora of the gastrointestinal tract is essential for mucosal protection, for immune education and for metabolism of fecal residue. Physiological disturbances of these processes, when they occur, result from: i) alteration of a microbial ecosystem, originally conserved by evolution; ii) reduced consumption of microorganisms; iii) invasion of pathogens; or iv) modern interventions. Recent data support the use of proven probiotic organisms in prevention and treatment of flora-related gastrointestinal disorders including inflammatory bowel disease, infectious and antibiotic related diarrheas, and post-resection disorders including pouchitis. Therapeutic activity of probiotic bacteria can be due to competition with pathogens for nutrients and mucosal adherence, production of antimicrobial substances, and modulation of mucosal immune functions. Although a promising treatment, controlled clinical trials are necessary to validate the benefit of probiotics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Short chain fatty acids in human large intestine, portal, hepatic and venous blood
Cummings, J. H., Pomare, E. W., Branch, W. J., Naylor, C. P., & Macfarlane, G. T. (1987) · Gut · doi:10.1136/gut.28.10.1221 · Cited by 3,119
The control and consequences of bacterial fermentation in the human colon
Cummings, J. H., & Macfarlane, G. T. (1991) · Journal of Applied Bacteriology · doi:10.1111/j.1365-2672.1991.tb02739.x · Cited by 1,499
Developmental microbial ecology of the neonatal gastrointestinal tract
Mackie, R. I., Sghir, A., & Gaskins, H. R. (1999) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/69.5.1035s · Cited by 1,360 · cited 2×
“In contrast, formula-fed babies have a more complex form with equal dominance between bifidobacteria and potentially pathogenic anaerobes [28, 29].”
BackgroundThe indigenous gastrointestinal microflora
Berg, R. (1996) · Trends in Microbiology · doi:10.1016/0966-842x(96)10057-3 · Cited by 1,153 · cited 2×
“Faecal samples are most frequently used to study the microflora, but the microbial inhabitants of faecal specimens represent the luminal environment which differ from the mucosal surface and crypt flora and are indicative more of the distal colon than the proximal intestines [14-17].”
BackgroundDunne, C., O’Mahony, L., Murphy, L., Thornton, G., Morrissey, D., O’Halloran, S., Feeney, M., Flynn, S., Fitzgerald, G., Daly, C., et al. (2001) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/73.2.386s · Cited by 922
Self-citationStark, P. L., & Lee, A. (1982) · Journal of Medical Microbiology · doi:10.1099/00222615-15-2-189 · Cited by 616 · cited 2×
“In contrast, formula-fed babies have a more complex form with equal dominance between bifidobacteria and potentially pathogenic anaerobes [28, 29].”
BackgroundOral probiotics can resolve urogenital infections
Reid, G., Bruce, A. W., Fraser, N., Heinemann, C., Owen, J., & Henning, B. (2001) · FEMS Immunology & Medical Microbiology · doi:10.1016/s0928-8244(00)00233-9 · Cited by 464
Gupta, P., Andrew, H., Kirschner, B. S., & Guandalini, S. (2000) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-200010000-00024 · Cited by 429
Linskens, R. K., Huijsdens, X. W., Savelkoul, P. H. M., Vandenbroucke-Grauls, C. M. J. E., & Meuwissen, S. G. M. (2001) · Scandinavian Journal of Gastroenterology · doi:10.1080/003655201753265082 · Cited by 233
Cited by
Heo, J. M., Opapeju, F. O., Pluske, J. R., Kim, J. C., Hampson, D. J., & Nyachoti, C. M. (2013) · Journal of Animal Physiology and Animal Nutrition · doi:10.1111/j.1439-0396.2012.01284.x · Cited by 769
The Role of Functional Foods, Nutraceuticals, and Food Supplements in Intestinal Health
Cencic, A., & Chingwaru, W. (2010) · Nutrients · doi:10.3390/nu2060611 · Cited by 581
Lee, J., Seto, D., & Bielory, L. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.10.043 · Cited by 362
van Zyl, W. F., Deane, S. M., & Dicks, L. M. T. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1831339 · Cited by 340
Scanlan, P. D., Shanahan, F., O'Mahony, C., & Marchesi, J. R. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00312-06 · Cited by 330
“(which have been commonly used as probiotics and have immunomodulatory activity [6, 43]), from Crohn’s disease patients in remission and relapse and compare their DGGE species profiles to a those for a control group.”
BackgroundSelf-citation
Metadata
- Authors
- O'Sullivan, G., Kelly, P., O'Halloran, S., Collins, C., Collins, J., Dunne, C., & Shanahan, F.
- Venue
- Current Pharmaceutical Design
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2005-01-01
- Volume
- 11
- Issue
- 1
- Pages
- 3-10
- ISSN
- 1381-6128 (ISSN-L)
- OpenAlex
- W2142135885
- Cited by
- 88
- References
- 12
- FWCI
- 13.93
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Probiotics: An Emerging Therapy. https://app.cochat.ai/papers/10.2174/1381612053382368
- The paper
- O'Sullivan, G., Kelly, P., O'Halloran, S., Collins, C., Collins, J., Dunne, C., & Shanahan, F. (2005). Probiotics: An Emerging Therapy. Current Pharmaceutical Design. https://doi.org/10.2174/1381612053382368
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.